- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/34 - Sulfur atoms to which a second hetero atom is attached
Patent holdings for IPC class C07D 213/34
Total number of patents in this class: 126
10-year publication summary
10
|
7
|
4
|
12
|
4
|
11
|
2
|
3
|
2
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Dow AgroSciences LLC | 1223 |
10 |
Bristol-myers Squibb Company | 4880 |
9 |
Corteva Agriscience LLC | 2682 |
8 |
F. Hoffmann-La Roche AG | 7947 |
6 |
Sumitomo Chemical Company, Limited | 9043 |
4 |
Novartis AG | 10744 |
3 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 58 |
3 |
Inflazome Limited | 85 |
3 |
Allergan, Inc. | 2347 |
2 |
Shenzhen China Star Optoelectronics Technology Co., Ltd. | 8476 |
2 |
Takeda Pharmaceutical Company Limited | 2708 |
2 |
Cadila Healthcare Limited | 317 |
2 |
Crysoptix KK | 38 |
2 |
Glucox Biotech AB | 15 |
2 |
JNC Corporation | 1561 |
2 |
JNC Petrochemical Corporation | 399 |
2 |
Kancera AB | 34 |
2 |
Kindred Biosciences, Inc. | 37 |
2 |
Kumiai Chemical Industry Co., Ltd. | 310 |
2 |
PIMCO 2664 Limited | 20 |
2 |
Other owners | 56 |